Features | Partner Sites | Information | LinkXpress
Sign In
SCHILLER AG
AMPRONIX
TERARECON, INC.

Patients in Shock Diagnosed with Whole-Body CT Show Significantly Lower Mortality Rates

By Medimaging International staff writers
Posted on 15 Aug 2013
German researchers have found that patients who are in shock and were diagnosed with whole-body computed tomography (CT) imaging showed substantially lower mortality rates.

The data analysis from the Trauma Register of the German Trauma Society (DGU) was performed by Stefan Huber-Wagner, MD, and colleagues in close cooperation with Prof. Rolf Lefering, PhD, from the Institute for Research in Operative Medicine (IFOM), University of Witten/Herdecke (Cologne, Germany).

Data of 16,719 severely injured patients from Germany, Belgium, Austria, Switzerland, and Slovenia were analyzed. The authors compared the observed and the expected mortality rate of severely injured patients with and without whole-body CT. The patients were divided in three groups: patients with severe shock, patients with moderate shock, and patients without shock.

In hemodynamically stable patients, the benefits of early whole-body CT were demonstrated before by this research group. However, the CT scanning in hemodynamically unstable patients is denied by many experts, although there was no scientific evidence so far. These specialists hold the view that physical assessment, basic traditional radiography and ultrasound are sufficient for patients in shock and that the use of whole-body CT leads to considerable time delay before emergency surgery.

Fifty-five percent of 9,233 patients (9,233) were studied with whole-body CT after admission to hospital. It takes between three and six minutes on average to conduct such an imaging scan. Eleven percent (1,821) of patients were in severe shock and 4,280 (26%) in moderate shock. Patients in shock, as reported, who were detected with whole-body CT showed significantly lower mortality rates. Furthermore, risk-adjusted mortality showed that the observed mortality in severely injured patients in shock was significantly lower with whole-body CT than the expected mortality, as compared to patients without whole-body CT. These calculations were based on the Revised Injury Severity Classification Score (RISC), which is a precise prognostic score in trauma care.

The authors concluded that their current hypothesis in trauma care is justified and furthermore found interesting insights regarding emergency treatment and requirements for trauma centers. According to their findings, the chance of survival in shock is increased by more than 25% if whole-body CT is performed. In spite of the supposed time delays caused by whole-body CT, the comprehensive knowledge of the complete injury pattern enables targeted life-saving emergency treatment. Strongly bleeding injuries can therefore be localized exactly and treated precisely. The cause shock can thereby be detected very quickly and accurately.

Prof. Peter Biberthaler, MD, director of the department of trauma surgery at University Hospital Klinikum rechts der Isar (Munich, Germany), emphasized, “With the required expertise, this innovative concept will probably lead to further decreased mortality rates of major trauma patients in the future.”

The study findings were published July 24, 2013, in the journal PLOS ONE.

Related Links:

Institute for Research in Operative Medicine, University of Witten/Herdecke



SuperSonic Imagine
RADCAL
RTI ELECTRONICS AB

Channels

MRI

view channel
Image: The Accent MRI pacemaker and Tendril MRI lead (Photo courtesy of St. Jude Medical).

US Patent Allows Full-Body MRI Technology for Use with Pacemakers

A California hospital is first in the United States to conduct magnetic resonance imaging (MRI) of a patient implanted with a new MRI-compatible pacemaker. Cardiothoracic surgeon Raymond Schaerf, MD... Read more

Ultrasound

view channel
Image: Very high magnification micrograph of fibrolamellar hepatocellular carcinoma showing the characteristic laminated fibrosis between the tumor cells with a low N/C ratio. H&E stain (Photo courtesy of Wikimedia Commons).

Hepatocellular Carcinoma Screening Linked with Curative Treatment and Longer Survival in Cirrhosis Patients

Investigators discovered that patients with cirrhosis who underwent surveillance (using liver ultrasound with or without measurement of serum alpha fetoprotein) for hepatocellular carcinoma (HCC) had cancers... Read more

Nuclear medicine

view channel
Image: Micrograph of Hodgkin lymphoma. Lymph node fine-needle aspiration (FNA) specimen. Field stain (Photo courtesy of Wikimedia Commons).

Early PET-Negative Stage I/II Hodgkin Lymphoma Patients Show Increased Risk of Early Relapse when Radiotherapy Is Not Used

Analysis of a new study indicates an increased risk of early relapse when excluding radiotherapy in early positron emission tomography (PET) scan-negative patients with stage I/II Hodgkin’s lymphoma.... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Enterprise Image-Viewing System Receives FDA Clearance for Mobile Diagnosis on All Modalities

An enterprise image-viewing system is now cleared in the United States for diagnosis on mobile devices, for all imaging modalities (except mammography). Calgary Scientific, Inc. (Calgary, AB, USA) recently reported their latest Class II clearance from the US Food and Drug Administration (FDA). Calgary Scientific worked... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.